Optimizing the safety of biologic therapy for IBD.

Nature Reviews. Gastroenterology & Hepatology
Shanika de SilvaR Panaccione

Abstract

The introduction of biologic therapy for the treatment of IBD has substantially changed its management. The safety concerns associated with biologic therapies include the increased risk of infection, autoimmunity, development of lymphoma and demyelinating disease, and the risk of worsening heart failure. There are several strategies for minimizing the risks associated with biologic therapies. Pretreatment strategies include taking a proper history from the patient, physical examination of the patient, screening for latent tuberculosis and ruling out sepsis. Vaccination of patients against vaccine preventable diseases is also recommended. During treatment, patients should be closely monitored and any symptoms that develop should be dealt with early. Education of physicians and patients is also important to allow the early detection of any adverse events.

References

Nov 1, 1993·Gastroenterology·S P James
Dec 1, 1993·Gastroenterology·P MunkholmV Binder
Jul 3, 1998·Gastroenterology·C Fiocchi
May 6, 1999·The New England Journal of Medicine·D H PresentS J van Deventer
Aug 7, 2001·Gastroenterology·J D Lewis
Oct 13, 2001·The New England Journal of Medicine·J KeaneM M Braun
May 23, 2002·Gastroenterology·William J Sandborn, Stephan R Targan
Jun 6, 2002·Lancet·Stephen B HanauerUNKNOWN ACCENT I Study Group
Oct 9, 2003·Annals of the Rheumatic Diseases·S Ghosh
Feb 24, 2004·Gastroenterology·Ananias C Diokno
Feb 27, 2004·The New England Journal of Medicine·Bruce E SandsSander J van Deventer
Apr 7, 2004·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·William S MowEric A Vasiliauskas
May 29, 2004·Gastroenterology·Paul RutgeertsSéverine Vermeire
Oct 9, 2004·Inflammatory Bowel Diseases·Bruce E SandsWalter Orenstein
Jun 11, 2005·The New England Journal of Medicine·Annette Langer-GouldDaniel Pelletier
Jun 11, 2005·The New England Journal of Medicine·B K Kleinschmidt-DeMasters, Kenneth L Tyler
Aug 9, 2005·Gastroenterology·Steven Woloshin, Lisa M Schwartz
Sep 7, 2005·Gastroenterology·Stefan SchreiberUNKNOWN CDP870 Crohn's Disease Study Group
Nov 4, 2005·The New England Journal of Medicine·William J SandbornUNKNOWN Evaluation of Natalizumab as Continuous Therapy (ENACT-2) Trial Group
Dec 13, 2005·The New England Journal of Medicine·Paul RutgeertsJean Frédéric Colombel
May 9, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Gary R LichtensteinWilliam J Sandborn
Jul 5, 2006·The American Journal of Gastroenterology·Gil Y MelmedEric A Vasiliauskas
Feb 3, 2007·Nature Clinical Practice. Gastroenterology & Hepatology·Livia BianconeFrancesco Pallone
Mar 9, 2007·Inflammatory Bowel Diseases·Alessandro LavagnaAngelo Pera
Jun 5, 2007·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Petar MamulaRobert N Baldassano
Jul 20, 2007·The New England Journal of Medicine·William J SandbornUNKNOWN PRECISE 1 Study Investigators
Jul 20, 2007·The New England Journal of Medicine·Stefan SchreiberUNKNOWN PRECISE 2 Study Investigators
Feb 13, 2008·Inflammatory Bowel Diseases·Sunanda Kane
Feb 26, 2008·Gastroenterology·Murat TorunerLaurence J Egan
May 1, 2008·Gut·Nick SheronIan Gilmore
Jun 14, 2008·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Laurent Peyrin-BirouletJean-Frédéric Colombel

❮ Previous
Next ❯

Citations

Apr 18, 2012·Inflammatory Bowel Diseases·Thomas T MacDonaldGiovanni Monteleone
Jan 24, 2016·Journal of Crohn's & Colitis·Micol ArtomChristine Norton
Apr 15, 2011·Clinics and Research in Hepatology and Gastroenterology·Claude Eugène
Nov 21, 2015·Journal of Agricultural and Food Chemistry·Yoshinori Mine, Hua Zhang
Dec 17, 2014·Amino Acids·Hua ZhangYoshinori Mine
Jul 31, 2012·Biochimica Et Biophysica Acta·Jennifer Kovacs-NolanYoshinori Mine
Dec 15, 2010·Nature Reviews. Immunology·Maya Saleh, Giorgio Trinchieri
Aug 22, 2014·Journal of Pediatric Gastroenterology and Nutrition·Hanh D VoSteven M Schwarz
Jan 23, 2020·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Afif N KulaylatEvangelos Messaris
Feb 26, 2020·Cellular & Molecular Immunology·Qiaoshi LianBing Sun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
A OrlandoMario Cottone
The New England Journal of Medicine
Jean Frederic ColombelSONIC Study Group
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
A OrlandoItalian Multicentric Study Group on Infliximab
© 2021 Meta ULC. All rights reserved